(Q41661425)

6 October 2017

1 reference

title

Achieving target hematocrit in dialysis patients: new concepts in iron management (English)

1 reference

6 October 2017

0 references

A R Nissenson

1

1 reference

6 October 2017

publication date

1 December 1997

1 reference

American Journal of Kidney Diseases

6 October 2017

published in

1 reference

6 October 2017

volume

30

1 reference

6 October 2017

issue

6

1 reference

6 October 2017

page(s)

907-911

1 reference

Iron management in end-stage renal disease

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990103-7

7 January 2021

Red cell ferritin as a diagnostic tool

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990103-7

7 January 2021

Detection of functional iron deficiency during erythropoietin treatment: a new approach

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990103-7

7 January 2021

Variation of serum iron concentration in young healthy men: within-day and day-to-day changes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990103-7

7 January 2021

Failure of serum ferritin levels to predict bone-marrow iron content after intravenous iron-dextran therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990103-7

7 January 2021

Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990103-7

7 January 2021

Iron metabolism indices for early prediction of the response and resistance to erythropoietin therapy in maintenance hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990103-7

7 January 2021

Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990103-7

7 January 2021

The safety of intravenous iron dextran in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990103-7

7 January 2021

Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990103-7

7 January 2021

Hepatic iron in dialysed patients given intravenous iron dextran

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990103-7

7 January 2021

Iron deficiency in maintenance hemodialysis patients: assessment of diagnosis criteria and of three different iron treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990103-7

7 January 2021

'Oversaturation' of transferrin after intravenous ferric gluconate (Ferrlecit(R)) in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990103-7

7 January 2021

Safety of intravenous injection of iron saccharate in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990103-7

7 January 2021

10.1016/S0272-6386(97)90103-7

Identifiers

DOI

1 reference

6 October 2017

1 reference